ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Zyus Life Sciences Corporation

Zyus Life Sciences Corporation (ZYUS)

0.83
0.02
(2.47%)
終了 9月30日 5:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.83
買値
0.81
売値
0.89
出来高
2,010
0.83 日の範囲 0.84
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.81
始値
0.84
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
70,847,000
配当利回り
-
PER
-1.38
1 株当たり利益 (EPS)
-0.6
歳入
351k
純利益
-42.59M

Zyus Life Sciences Corporation について

セクター
Pharmaceutical Preparations
業界
Oil And Gas Field Expl Svcs
ウェブサイト
本社
Toronto, Ontario, Can
設立
2023
Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the トロントベンチャー取引所 with ticker ZYUS. The last closing price for Zyus Life Sciences was $0.81. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0.00 to $ 0.00.

Zyus Life Sciences currently has 70,847,000 shares in issue. The market capitalisation of Zyus Life Sciences is $57.39 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.38.

ZYUS 最新ニュース

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
OZValkea Resources Corp
 0.40
(1,233.33%)
181.01k
FWTCForward Water Technologies Corp
$ 0.12
(1,100.00%)
48k
INSPInspire Semiconductor Holdings Inc
$ 0.20
(53.85%)
282.8k
TNO.HTerreno Resources Corp
$ 0.015
(50.00%)
4k
VISVisionstate Corp
$ 0.045
(50.00%)
4.06M
GRZGold Reserve Inc
$ 2.10
(-42.15%)
63.25k
ICRSIcarus Capital Corp
$ 0.015
(-40.00%)
3.5k
KAPAKapa Gold Inc
$ 0.03
(-40.00%)
17k
SSESilver Spruce Resources Inc
$ 0.01
(-33.33%)
708.33k
GBUGabriel Resources Ltd
$ 0.01
(-33.33%)
38.27k
VISVisionstate Corp
$ 0.045
(50.00%)
4.06M
VOValOre Metals Corp
$ 0.08
(0.00%)
3.28M
BFMBedford Metals Corp
$ 0.90
(-14.29%)
2.49M
TECTTectonic Metals Inc
$ 0.06
(0.00%)
2.48M
NBLCNobel Resources Corp
$ 0.06
(20.00%)
2.17M

最近閲覧した銘柄

Delayed Upgrade Clock